The paper was recently published in Biomolecules Journal.
This innovative research investigated whether genetic osteoblast-specific inactivation of the chemokine receptor Ccr2 at different times during post-traumatic osteoarthritis (OA) progression improves joint structures, bone parameters and pain.
You can access the article, titled “CC-Chemokine Receptor-2 Expression in Osteoblasts Contributes to Cartilage and Bone Damage during Post-Traumatic Osteoarthritis,” via this link.